| Financial Year |
March 31 2023 |
| Monetary Funds |
816,022,985.40 |
| Held-for-trading Financial Assets |
100,464,126.73 |
| Notes Receivable |
133,594,179.88 |
| Accounts Receivable |
271,083,348.15 |
| Advances to Suppliers |
30,540,744.39 |
| Other Receivables |
6,413,499.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
399,582,650.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
72,517,531.29 |
| Total Current Assets |
1,857,763,938.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
512,966,585.53 |
| Under-construction Projects |
66,502,247.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
157,265,330.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,579,147.44 |
| Deferred Income Tax Assets |
4,312,970.64 |
| Other Non-Current Assets |
14,044,880.04 |
| Sub-Total of Non-Current Assets |
876,413,212.81 |
| Total Assets |
2,734,177,151.27 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
347,636,252.89 |
| Accounts Payable |
148,465,032.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,830,056.44 |
| Taxes Payable |
6,715,099.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,770,402.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,290,594.97 |
| Other Current Liabilities |
59,665,342.09 |
| Sub-Total of Current Liabilities |
654,711,408.63 |
| Long-term Loans |
-- |
| Bonds Payable |
382,621,968.38 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,200,218.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
449,804,702.78 |
| Total Liabilities |
1,104,516,111.41 |
| Paid-In Capital(Or Share Stock) |
162,316,494.00 |
| Capital Surplus |
641,384,643.72 |
| Surplus Reserve |
88,155,706.34 |
| LESS:Treasury Stock |
13,649,984.00 |
| Undistributed Profits |
639,494,576.71 |
| Minority Stockholder's Interest |
-473,399.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,630,134,439.70 |
| Owner's Equity（Stockholder's Equity） |
1,629,661,039.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,734,177,151.27 |
